More than 1.4 million passengers were seen at airports across the country on Friday alone – a record for an epidemic era.
De Peter, Dean of the National School of Tropical Medicine at the Baylor College College of Medicine. Peter Hotz, “What we’re doing is essentially spreading the B1.1 .. variant across the country.”
That’s because the U.S. The number of previous infections and now the number of vaccinations in has begun to form “backstory enough” to prevent a second spike, Dr. Scott Gottlieb, former commissioner of the Food and Drug Administration, told CBS’s “Face the Nation” on Sunday.
“I think what you can see is the plateau for the period before we continue on the downtrend – largely because B1.1. Is becoming more prevalent, in large part because we’re back very quickly. Pulling, in terms of taking off our masks and removing the mitigation, ”he said.
Others say it is difficult to predict what will happen.
“It’s very difficult to say,” Hotez told CNN. “We’re in a race, that’s what it comes down to. We’ve got a dose (Covid-19 vaccine) in about a quarter of the U.S. population … and it could go anywhere from now on.”
“This is the reason why it is really important for governors to continue the course and implement masks and social distance,” he said.
The spring breakers worry the officers
Emergency Physician Dr. “I want people to at least mask,” Megan Renny told CNN on Sunday, referring to the spring break crowd. “I expect that many of these young adults have been vaccinated and seeing them gather in that crowd, even from the outside, scares me that they will bring the B1.1 var variant back to their home state and spread it. Will. “
Other experts have expressed similar concerns, warning that all returning vacationers could help increase Covid-1 sur in other parts of the country, especially now that the number of vaccinations is still so low.
“We are very concerned about the transmissible variants. Many of them have been through our travel corridors, so we are more cautious with travel right now,” Wensky told CNN.
The governor says vaccine shrinkage is a concern
More than 44 million people – about 13.3% of the population – have been fully vaccinated, the data show.
Those challenges include vaccination hesitation and political divisions. SSRS Recently made by CNN. Polls show that when %%% of Democrats say they’ve got a dose of the vaccine or plan to get one, that’s down to 0% among Republicans.
When asked why he believes there is skepticism among Republicans, Arkansas Govt. Asa Hutchinson told CNN that he believes it is “a natural resistance to government and skepticism about it.”
“Hesitation is a concern not only here, but across the country, and I as a country expect that we will get 0% in the vaccination rate of the population. But we will have a difficult time of 0% to 70%. And it’s about overcoming atheism. “It’s about education … but it’s also about confidence,” he said.
As more Americans see others getting vaccinated, the governor said he expects vaccination acceptance rates to increase.
In Missouri, Governor Mike Parsons said late last week that while he encourages everyone to be vaccinated, “there will still be a certain amount of people who are not vaccinated and they have the right to do so.”
“We’re sure everyone understands the importance of the vaccine, and we’ve done a better job of maintaining respect for people who don’t yet want to be vaccinated, and how many people we see is becoming a challenge. Yes, but we can do everything. “
New data on the AstraZeneca vaccine
A new UK-based clinical trial has shown that vaccines are effective against serious disease and hospital admissions, and that vaccination is effective.
The findings of the new Phase 3 trial, which involved more than 32,000 participants, could boost confidence in the vaccine, which was originally developed by Oxford University.
The trial showed the vaccine was well tolerated and there were no safety concerns, the company said. According to AstraZeneca, an independent committee found that “21,583 participants who received at least one dose of the vaccine did not have an increased risk of thrombosis or events characterized by thrombosis.”
The new data comes from Phase 3 clinical trials conducted in the U.S., Chile and Peru. AstraZeneca says it plans to submit the findings to a scientific journal for peer review.
CNN’s Chuck Johnston, Niamh Kennedy, Karma Hassan, Dina Hackney and Lure Ren Mascarenhas contributed to the report.
.
